“Scrappy.” That’s a one-word summation of GigaGen’s approach to both the business and science of biotech.
“When you’re a new company, you have to be scrappy and clever. When I founded GigaGen in 2011, I didn’t have a big war chest of money, so I had to find a way to be competitive. That’s central for survival,” says Dave Johnson, Ph.D., CEO of GigaGen.
Surge Workflow Performs Complete Interrogation